NEW YORK (GenomeWeb) – Dutch ag-bio company KeyGene announced today that it has licensed its proprietary sequence-based genotyping technology to LGC and Bayer's Crop Science division.

Under the terms of the separate agreements, KeyGene has given Bayer a non-exclusive license for the in-house use of the SBG technology for crop improvement, and has given LGC a non-exclusive license for the commercial offering and use of SBG technology across all species, including field and vegetable crops, for the global market, the company said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.